Statistics for The Safety and Efficacy of First-Line Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: a Multicenter Real-World Study From Turkey
Total visits
| views | |
|---|---|
| The Safety and Efficacy of First-Line Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: a Multicenter Real-World Study From Turkey | 1 |
Total visits per month
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 1 |
| April 2026 | 0 |
Top country views
| views | |
|---|---|
| China | 1 |